{"id":"https://openalex.org/W8098734","doi":null,"title":"Anti-VEGF in treatment of diabetic macular edema.","display_name":"Anti-VEGF in treatment of diabetic macular edema.","publication_year":2011,"publication_date":"2011-09-01","ids":{"openalex":"https://openalex.org/W8098734","mag":"8098734","pmid":"https://pubmed.ncbi.nlm.nih.gov/22220397"},"language":"en","primary_location":{"id":"pmid:22220397","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22220397","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Collegium antropologicum","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://hrcak.srce.hr/72217","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038435039","display_name":"Ivan Boras","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405262387","display_name":"Specijalna bolnica za oftalmologiju Svjetlost","ror":"https://ror.org/030jdch10","country_code":"HR","type":"healthcare","lineage":["https://openalex.org/I4405262387"]}],"countries":["HR"],"is_corresponding":false,"raw_author_name":"Ivan Boras","raw_affiliation_strings":["Universitiy Eye Clinic \"Svjetlost\", Zagreb, Croatia. ivan.boras@svjetlost.hr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universitiy Eye Clinic \"Svjetlost\", Zagreb, Croatia. ivan.boras@svjetlost.hr","institution_ids":["https://openalex.org/I4405262387"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113773689","display_name":"Ratimir Lazi\u0107","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ratimir Lazi\u0107","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049136432","display_name":"Nikica Gabri\u0107","orcid":"https://orcid.org/0000-0003-4975-4295","observed_orcids":["https://orcid.org/0000-0003-4975-4295"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nikica Gabri\u0107","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040896417","display_name":"Marko Luki\u0107","orcid":"https://orcid.org/0000-0002-7636-8368","observed_orcids":["https://orcid.org/0000-0002-7636-8368"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marko Luki\u0107","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5031831634","display_name":"Iva Dekaris","orcid":"https://orcid.org/0000-0003-4133-9783","observed_orcids":["https://orcid.org/0000-0003-4133-9783"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Iva Dekaris","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.1598,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.76684341,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"35 Suppl 2","issue":null,"first_page":"15","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11377","display_name":"Retinal and Macular Surgery","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/diabetic-macular-edema","display_name":"diabetic macular edema","score":0.9980000257492065},{"id":"https://openalex.org/keywords/ranibizumab","display_name":"ranibizumab","score":0.9509999752044678},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.996999979019165},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.8949999809265137},{"id":"https://openalex.org/keywords/intravitreal-injection","display_name":"intravitreal injection","score":0.828000009059906},{"id":"https://openalex.org/keywords/central-retinal-thickness","display_name":"central retinal thickness","score":0.9150000214576721},{"id":"https://openalex.org/keywords/visual-acuity","display_name":"visual acuity","score":0.9879999756813049},{"id":"https://openalex.org/keywords/diabetic-retinopathy","display_name":"diabetic retinopathy","score":0.9589999914169312},{"id":"https://openalex.org/keywords/treatment-efficacy-and-safety","display_name":"treatment efficacy and safety","score":0.621999979019165}],"concepts":[{"id":"https://openalex.org/C2781100027","wikidata":"https://www.wikidata.org/wiki/Q414270","display_name":"Ranibizumab","level":4,"score":0.9596812725067139},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9554792642593384},{"id":"https://openalex.org/C2779829184","wikidata":"https://www.wikidata.org/wiki/Q631361","display_name":"Diabetic retinopathy","level":3,"score":0.7430678606033325},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.7344654202461243},{"id":"https://openalex.org/C2780347916","wikidata":"https://www.wikidata.org/wiki/Q1813737","display_name":"Macular edema","level":3,"score":0.6502516865730286},{"id":"https://openalex.org/C2778257484","wikidata":"https://www.wikidata.org/wiki/Q555066","display_name":"Visual acuity","level":2,"score":0.6440003514289856},{"id":"https://openalex.org/C2985127711","wikidata":"https://www.wikidata.org/wiki/Q631361","display_name":"Diabetic macular edema","level":4,"score":0.5987748503684998},{"id":"https://openalex.org/C2780886150","wikidata":"https://www.wikidata.org/wiki/Q152234","display_name":"Edema","level":2,"score":0.5751858353614807},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4857504963874817},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.46065446734428406},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.44652512669563293},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4454110562801361},{"id":"https://openalex.org/C2780827179","wikidata":"https://www.wikidata.org/wiki/Q422001","display_name":"Retinal","level":2,"score":0.4233853816986084},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3401321768760681},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.281525194644928},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.23072946071624756},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21629446744918823},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.20198103785514832},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.08176156878471375},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069579","descriptor_name":"Ranibizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003930","descriptor_name":"Diabetic Retinopathy","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003930","descriptor_name":"Diabetic Retinopathy","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008269","descriptor_name":"Macular Edema","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008269","descriptor_name":"Macular Edema","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D014792","descriptor_name":"Visual Acuity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D041623","descriptor_name":"Tomography, Optical Coherence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"pmid:22220397","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22220397","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Collegium antropologicum","raw_type":"Clinical Trial"},{"id":"pmh:oai:hrcak.srce.hr:72217","doi":null,"is_oa":true,"landing_page_url":"http://hrcak.srce.hr/72217","pdf_url":null,"source":{"id":"https://openalex.org/S4306400071","display_name":"University of Zagreb University Computing Centre (SRCE)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I181343428","host_organization_name":"University of Zagreb","host_organization_lineage":["https://openalex.org/I181343428"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Collegium antropologicum","raw_type":"info:eu-repo/semantics/article"},{"id":"mag:8098734","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22220397","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"pmh:oai:hrcak.srce.hr:72217","doi":null,"is_oa":true,"landing_page_url":"http://hrcak.srce.hr/72217","pdf_url":null,"source":{"id":"https://openalex.org/S4306400071","display_name":"University of Zagreb University Computing Centre (SRCE)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I181343428","host_organization_name":"University of Zagreb","host_organization_lineage":["https://openalex.org/I181343428"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Collegium antropologicum","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":1,"referenced_works":["https://openalex.org/W1596865488"],"related_works":["https://openalex.org/W4221084379","https://openalex.org/W2161588304","https://openalex.org/W2051559287","https://openalex.org/W2103965396","https://openalex.org/W4238986165","https://openalex.org/W4298267924","https://openalex.org/W7220697250","https://openalex.org/W2093786875","https://openalex.org/W125642111","https://openalex.org/W2558041207"],"abstract_inverted_index":{"Diabetic":[0],"macular":[1,59],"edema":[2,60],"is":[3],"the":[4,35,88,173,176,194],"leading":[5],"cause":[6],"of":[7,25,39,44,91,100,102,114,129,152,166],"moderate":[8],"visual":[9,52],"deterioration":[10],"in":[11,42,51,55,98,158,163,183,203],"patients":[12,56,63,124],"with":[13,57,73,160],"diabetic":[14,58],"retinopathy.":[15],"Ranibizumab)":[16],"blocks":[17],"vascular":[18],"endothelial":[19],"growth":[20],"factor":[21],"(VEGF)":[22],"induced":[23],"hyperpermeability":[24],"blood":[26],"vessels.":[27],"In":[28],"this":[29],"prospective":[30],"case":[31,99],"series":[32],"we":[33],"investigated":[34],"efficacy":[36],"and":[37,49,70,77,96,112,137,185,199],"safety":[38],"anti-VEGF":[40],"treatment":[41,180],"reduction":[43],"central":[45],"retinal":[46],"thickness":[47],"(CRT)":[48],"improvement":[50,90,151],"acuity":[53],"(VA)":[54],"(DME).":[61],"9":[62,123],"were":[64,79,169,190],"followed":[65],"up":[66],"for":[67],"6":[68,117],"months":[69],"treated":[71],"monthly":[72],"intravitreal":[74],"ranibizumab.":[75],"VA":[76,107,120,153,184],"CRT":[78,111,138],"measured":[80],"at":[81,116],"each":[82],"visit.":[83],"Treatment":[84],"was":[85,94,157,181],"discontinued":[86],"as":[87],"peak":[89],"either":[92],"parameter":[93],"reached":[95,208],"reinstituted":[97],"deterioration/recurrence":[101],"edema.":[103],"Study":[104],"endpoints":[105],"included:":[106],"using":[108],"ETDRS":[109],"chart,":[110],"number":[113],"injections":[115,168,189],"months.":[118],"Mean":[119,165],"from":[121,140],"all":[122],"increased":[125],"by":[126],"0.3":[127],"lines":[128],"logMAR":[130],"(p":[131],"<":[132],"0.05":[133],"compared":[134],"to":[135,145,171,192,205],"baseline),":[136],"decreased":[139],"515":[141],"+/-":[142,147],"123":[143],"microm":[144],"310":[146],"110":[148],"microm.":[149],"The":[150],"after":[154],"ranibizumab":[155],"injection":[156],"correlation":[159],"a":[161],"decrease":[162],"CRT.":[164,187],"4":[167],"needed":[170,191],"control":[172,193],"disease":[174],"during":[175],"follow-up":[177],"period.":[178],"Ranibizumab":[179],"effective":[182],"reducing":[186],"Several":[188],"disease.":[195],"Regular":[196],"OCT":[197],"examinations":[198],"retreatment":[200],"are":[201],"advised":[202],"order":[204],"maintain":[206],"initially":[207],"VA.":[209]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}